Can albumin reduce adverse effects of paracentesis in patients with cirrhosis?

Updated: Jul 05, 2018
  • Author: Gil Z Shlamovitz, MD, FACEP; Chief Editor: Vikram Kate, MBBS, MS, PhD, FRCS, FACS, FACG, FRCS(Edin), FRCS(Glasg), FIMSA, MAMS, MASCRS  more...
  • Print
Answer

A meta-analysis suggests that the use of albumin in cirrhotic patients undergoing paracentesis reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment. [18]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!